Isaac Blech Net Worth

The estimated Net Worth of Isaac Blech is at least $26.8 mil dollars as of 15 March 2019. Mr. Blech owns over 10,000 units of InspireMD Inc stock worth over $26,800 and over the last 10 years he sold NSPR stock worth over $0. In addition, he makes $0 as Independent Vice Chairman of the Board at InspireMD Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Blech NSPR stock SEC Form 4 insiders trading

Isaac has made over 3 trades of the InspireMD Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of NSPR stock worth $26,800 on 15 March 2019.

The largest trade he's ever made was buying 16,000 units of InspireMD Inc stock on 25 July 2017 worth over $19,840. On average, Isaac trades about 947 units every 16 days since 2015. As of 15 March 2019 he still owns at least 10,000 units of InspireMD Inc stock.

You can see the complete history of Mr. Blech stock trades at the bottom of the page.

Isaac Blech biography

Isaac Blech is Independent Vice Chairman of the Boardof the Company. He is a renowned biotechnology entrepreneur and investor, who, over the past 32 years, has founded and served on the board of companies which have produced major advances in a broad array of diseases, including the diagnosis of chlamydia, herpes, syphilis and HIV, and the treatment of cystic fibrosis, sexual dysfunction, multiple myeloma and brain cancer. The companies he established include Celgene Corporation (NASDAQ: CELG), ICOS Corporation, Nova Pharmaceutical Corporation, Pathogenesis Corporation and Genetics Systems Corporation. Mr. Blech’s current roles include director and founder of Cerecor, Inc. (NASDAQ: CERC), a public company developing new treatments for central nervous system disorders, director of ContraFect Corporation (NASDAQ: CFRX), a public infectious disease company, director of Medgenics, Inc. (NYSE: MDGN), a public company creating new treatments for rare diseases, and vice chairman of Edge Therapeutics, Inc. (NASDAQ: EDGE), a public company that treats life-threatening neurological conditions. He is vice chairman of Centrexion Corporation, a private company which is developing new modalities of pain control, vice chairman of Regenovation, Inc., a private company developing new ways to regenerate human tissue, vice chairman of X4 Pharmaceuticals, a private cancer immunology company, vice chairman of Sapience Therapeutics, a private oncology company and vice chairman of Aridis Pharmaceuticals, a private company with a product to treat pneumonia. He also serves as vice chairman of WaveGuide Corporation, a private company developing the world’s smallest NMR machine, vice chairman of root9B Technologies, Inc. (OTC: RTNB), a public cyber security company, and vice chairman of The SpendSmart Payments Company (OTC: SSPC), a public electronic rewards company.

How old is Isaac Blech?

Isaac Blech is 66, he's been the Independent Vice Chairman of the Board of InspireMD Inc since 2016. There are 2 older and 8 younger executives at InspireMD Inc. The oldest executive at InspireMD Inc is Dr. Sol J. Barer Ph.D., 74, who is the Special Advisor to the Board.

What's Isaac Blech's mailing address?

Isaac's mailing address filed with the SEC is C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON, MA, 02116.

Insiders trading at InspireMD Inc

Over the last 13 years, insiders at InspireMD Inc have traded over $1,684,082 worth of InspireMD Inc stock and bought 3,887,125 units worth $5,293,286 . The most active insiders traders include Sol J Barer, Eli Bar, eGary S Roubin. On average, InspireMD Inc executives and independent directors trade stock every 97 days with the average trade being worth of $319,459. The most recent stock trade was executed by Gary S Roubin on 30 November 2023, trading 50,000 units of NSPR stock currently worth $126,500.

What does InspireMD Inc do?

inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.

Complete history of Mr. Blech stock trades at Cerecor Inc, ContraFect Corp, Diffusion Pharmaceuticals Inc, eInspireMD Inc

InspireMD Inc executives and stock owners

InspireMD Inc executives and other stock owners filed with the SEC include:

• Marvin L. Slosman,
  Pres, CEO & Director
• Craig Shore,
  CFO, Chief Admin. Officer, Sec. & Treasurer
• Craig Shore,
  Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary
• Campbell Rogers,
  Independent Director
• Michael Berman,
  Independent Director
• Gary Roubin,
  Director
• Thomas Kester,
  Director
• Agustin Gago,
  Executive Vice President, Chief Commercial Officer
• Isaac Blech,
  Independent Vice Chairman of the Board
• Marvin Slosman,
  Chief Executive Officer, Director
• Paul Stuka,
  Chairman of the Board
• Dr. Sol J. Barer Ph.D.,
  Special Advisor to the Board
• Amir Kohen,
  VP of Fin. & International HR
• Andrea Tommasoli,
  Sr. VP of Global Sales & Marketing
• Roei Samuri,
  VP of Operations
• Sol J Barer,
  Director
• James J Barry,
  President and CEO
• James J Loughlin,
  Director
• Alan Milinazzo,
  President and CEO
• Eric L. Olson,
  VP of Global Sales Operations
• Eli Bar,
  CTO InspireMD Ltd.
• Asher Holzer,
  Director
• Eyal Weinstein,
  Director
• Kathryn Arnold,
  Director
• Shane Thomas Gleason,
  Chief Commercial Officer
• Patrick Verta,
  EVP Clinical/Medical Affairs